The product labeling information includes all published material associated to a drug. Product labeling documents include information like generic names, active ingredients, ingredient strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.
Active Ingredient(S) In Each Tablet
Fexofenadine hydrochloride USP, 180 mg
Temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:§ runny nose§ sneezing§ itchy, watery eyes§ itching of the nose or throat
Do Not Use
If you have ever had an allergic reaction to this product or any of its ingredients.
Ask A Doctor Before Use If
You have kidney disease. Your doctor should determine if you need a different dose.
When Using This Product
§ do not take more than directed § do not take at the same time as aluminum or magnesium antacids§ do not take with fruit juices (see Directions)
Stop Use And Ask A Doctor If
An allergic reaction to this product occurs. Seek medical help right away.If pregnant or breast-feeding, ask a health professional before use.
Keep Out Of Reach Of Children
In case of overdose, get medical help or contact a Poison Control Center right away.
Adults and children 12 years of age and overtake one 180 mg tablet with water once a day; do not take more than 1 tablet in 24 hours children under 12 years of age do not use adults 65 years of age and older ask a doctor consumers with kidney disease ask a doctor
• Tamper-Evident: Do not use if printed foil seal under cap is missing • store between 20° and 25°C (68° and 77°F) • protect from excessive moisture
Colloidal silicon dioxide, hypromellose, light liquid paraffin, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, pregelatinized starch, red iron oxide, sodium starch glycolate, talc, titanium dioxide and yellow iron oxide.
Call 1-800-206-7821Manufactured for: Northstar Rx LLC Memphis, TN 38141. Manufactured by: Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahabubnagar - 509 301, India. Mfg. Lic. No.: 50/MN/AP/2009/F/R Issued: 11/2018
* Please review the disclaimer below.